Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-24-000069

Director sold 6,250 shares at an average $116.28 ($726,731)

  • Director acquired 6,250 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Loxam Teri Director 2024-09-17 Option exercise 10b5-1 +6,250 $22.70 $141,875 13,425 D
Loxam Teri Director 2024-09-17 Sale 10b5-1 −241 $114.64 $27,628 13,184 D
Loxam Teri Director 2024-09-17 Sale 10b5-1 −1,445 $115.32 $166,634 11,739 D
Loxam Teri Director 2024-09-17 Sale 10b5-1 −4,308 $116.62 $502,387 7,431 D
Loxam Teri Director 2024-09-17 Sale 10b5-1 −256 $117.51 $30,083 7,175 D
Derivatives
Loxam Teri Director 2024-09-17 Option exercise · Stock Option (right to buy) 10b5-1 −6,250 12,500 D
Open-market sales · 6,250 sh · avg $116.28 · $726,731
Loading xslF345X05/wk-form4_1726691078.xml…